Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : LLY crawled date : 2021 - 07 - 09 save search
Worldwide Infusion Therapy Industry to 2026 - Rapid Technological Innovations Present Opportunities
Published: 2021-07-09 (Crawled : 21:00) - prnewswire.com
BAX | $39.65 0.33% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
BDX | $233.15 0.41% 0.15% 890K
|
Health Technology
| Email alert
Add to watchlist
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
ICUI | $96.88 1.04% 1.03% 140K
|
Health Technology
| Email alert
Add to watchlist
OPCH | $30.94 2.21% 2.17% 1.6M
|
Health Services
| Email alert
Add to watchlist
therapy
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-07-09 (Crawled : 18:17) - fda.gov
REGN | $893.66 -0.84% -0.84% 450K
|
Health Technology
| Email alert
Add to watchlist
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
| Email alert
Add to watchlist
CLVS | $0.0812 -3.94%
|
Health Technology
| Email alert
Add to watchlist
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
| Email alert
Add to watchlist
KPTI | $1.265 -8.33% -9.09% 1.3M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
| Email alert
Add to watchlist
ADCT | $4.76 -4.03% 0.0% 280K
|
Health Technology
| Email alert
Add to watchlist
YMAB | $14.97 -0.93% -0.94% 410K
|
Health Technology
| Email alert
Add to watchlist
BPMC | News | $88.9 0.59% 0.58% 730K
|
Health Technology
| Email alert
Add to watchlist
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
| Email alert
Add to watchlist
AVEO | $15.0 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
cancer approval
Oncology Therapeutics Market to exceed US$ 247.5 Billion by 2027 Globally |CAGR: 8.2%| UnivDatos Market Insights
Published: 2021-07-09 (Crawled : 15:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.27%
H: 0.89%
C: 0.69%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.01%
H: 1.3%
C: 0.69%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.49%
H: 1.17%
C: 0.87%
market
Mirikizumab Up-Regulates Genes Associated with Mucosal Healing in Ulcerative Colitis for Up to One Year in Phase 2 Study
Published: 2021-07-09 (Crawled : 11:00) - prnewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
phase 2 ulcerative colitis
Innovent Announces NMPA Acceptance of New Drug Application for the FGFR1/2/3 Inhibitor (Pemigatinib) for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement
Published: 2021-07-09 (Crawled : 01:00) - prnewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: -0.34%
H: 1.2%
C: 1.1%
new drug treatment drug
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.